ASCEND BY NTHRYS
Research Abroad Products

Molecular Medicine Project Topics

Browse all focused areas across all project categories under this field.

Showing 169–180 of 200 project topics
Molecular Imaging Biomarker Platform for Cardiac Therapeutics
An imaging informatics platform that integrates PET, SPECT, and cardiac MRI data with molecular signatures to enable mechanism-of-action confirmation in cardiovascular trials. Supports regulatory submissions, biomarker-driven patient enrichment, and imaging CRO partnerships with tiered licensing models.
Molecular Medicine Cardiovascular Drug Dev Click to view more details →
Next-Generation Sequencing Analysis Coronary Artery Disease
A bioinformatics software suite that identifies rare and common genetic variants driving CAD susceptibility and treatment response through variant interpretation and pathway analysis. Monetizes through diagnostic laboratory partnerships, pharmaceutical research collaborations, and precision medicine test commercialization.
Molecular Medicine Cardiovascular Drug Dev Click to view more details →
AI-Powered Pathogen Genomic Sequencing Analysis Platform
A cloud-based SaaS platform that leverages machine learning to rapidly sequence and analyze pathogen genomes for variant identification and drug resistance prediction. Enables pharmaceutical companies and diagnostic labs to accelerate time-to-market for targeted therapeutics while reducing sequencing costs by up to 40%.
Molecular Medicine Infectious Disease Platforms Click to view more details →
Real-Time Viral Load Monitoring Software as Service
A mobile and web-integrated platform that aggregates real-time viral load data from networked diagnostic devices for continuous patient monitoring and clinical decision support. Generates recurring subscription revenue through per-patient monthly fees and enables remote patient management workflows for healthcare systems.
Molecular Medicine Infectious Disease Platforms Click to view more details →
High-Throughput Antimicrobial Susceptibility Testing Automation Suite
An integrated hardware-software solution that automates and accelerates AST screening for antibiotic resistance across microbial isolates using molecular markers and digital image analysis. Delivers licensing revenue and consumables sales while reducing laboratory turnaround time from 48 hours to 4 hours.
Molecular Medicine Infectious Disease Platforms Click to view more details →
Infectious Disease Biomarker Discovery Engine Commercial Platform
A proprietary computational platform that identifies novel molecular biomarkers for rapid infectious disease diagnosis using multi-omics data integration and predictive analytics. Monetizes through biomarker licensing agreements with diagnostic manufacturers and research collaboration fees with pharmaceutical partners.
Molecular Medicine Infectious Disease Platforms Click to view more details →
Personalized Infection Treatment Prediction Algorithm Service
A data-driven SaaS tool that predicts optimal antibiotic or antiviral treatment responses based on patient genetic profiles and pathogen molecular characteristics. Captures value through per-test licensing fees with healthcare providers and integration partnerships with electronic health record systems.
Molecular Medicine Infectious Disease Platforms Click to view more details →
Multiplexed Pathogen Detection Kit Development and Licensing
A commercial molecular diagnostic kit platform capable of simultaneous detection of multiple infectious agents through PCR and next-generation sequencing technologies. Generates revenue through kit sales, licensing fees to diagnostic companies, and royalties on clinical adoption across hospital networks.
Molecular Medicine Infectious Disease Platforms Click to view more details →
Infectious Disease Epidemiological Surveillance Intelligence Dashboard
A real-time analytics dashboard that aggregates molecular epidemiological data from distributed laboratories to track pathogen spread, mutations, and outbreak patterns at regional and global scales. Monetizes through institutional subscription models targeting public health agencies, hospital systems, and pharmaceutical manufacturers for pipeline development.
Molecular Medicine Infectious Disease Platforms Click to view more details →
Drug Target Validation Platform for Infectious Disease Therapeutics
A high-throughput molecular screening platform that validates and ranks novel therapeutic targets in pathogens using CRISPR, RNA interference, and structural biology tools. Enables biotech and pharma companies to de-risk early-stage programs and accelerates licensing opportunities with downstream development partners.
Molecular Medicine Infectious Disease Platforms Click to view more details →
Clinical Metagenomics Analysis and Reporting Software Solution
A cloud-native software suite that processes metagenomic sequencing data to identify causative agents of infections, including rare and atypical pathogens, with clinician-friendly reporting. Captures recurring revenue through per-sample analysis fees and enterprise licensing with hospital systems and reference laboratories.
Molecular Medicine Infectious Disease Platforms Click to view more details →
Molecular Infection Risk Stratification Platform Healthcare Analytics
An AI-driven clinical decision support platform that stratifies patient infection risk using molecular biomarkers, microbial load data, and clinical variables to guide preventive interventions. Delivers value through licensing fees to hospital networks, integration partnerships with EHR vendors, and potential outcomes-based revenue sharing models.
Molecular Medicine Infectious Disease Platforms Click to view more details →